TPN is frequently administered to premature infants unable to tolerate enteral nutrition. TPN provides systemic energy and nutrients but has been associated with intestinal atrophy, abnormal BB ...

Pompe disease also known as Glycogen Storage Disease / Acid Maltase Deficiency is a rare genetic disease caused by the buildup of a sugar called glycogen in the body’s cells. It is caused by the ...

Intrauterine growth retardation (IUGR) affects almost 10% of infants born in the United States. It may be responsible for delayed gastrointestinal function and is an important cause of perinatal ...

The first-ever treatment for an extremely rare and often fatal genetic disease that interferes with the body’s ability to tap built-up stores of sugar for energy received federal approval Friday. The ...

Enzymes are biocatalysts produced by living cells in organisms, most of which are usually globular proteins. These enzymes can effectively catalyze various biochemical reactions and promote the ...

Creative Enzymes, a global leader in diagnostic enzyme manufacturing and supply, is dedicated to offering a wide range of enzyme products as well as customized enzyme-related services for medical and ...

WASHINGTON — The first-ever treatment for an extremely rare and often fatal genetic disease that interferes with the body’s ability to tap built-up stores of sugar for energy received federal last ...